查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576528

智慧胰島素筆市場規模、佔有率、預測、趨勢分析：按產品、連接性、相容性、管道 - 到 2031 年的全球預測

Smart Insulin Pens Market Size, Share, Forecast, & Trends Analysis by Product, Connectivity, Compatibility, and Channel - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 | 商品交期: 5-7個工作天內

價格

預計到 2031 年，智慧胰島素筆市場將達到 7.765 億美元，2024 年至 2031 年複合年增長率為 11.2%。

經過廣泛的二次和初步研究以及對市場情景的詳細分析，本報告對關鍵行業驅動因素、限制因素、課題和機會進行了分析。智慧胰島素筆市場的成長是由糖尿病盛行率不斷上升、對數位健康解決方案的日益偏好、智慧胰島素筆的技術進步、對藥物自我管理的需求不斷增加以及全球提高糖尿病意識的努力所推動的。 。然而，智慧胰島素筆的高成本和替代品的稀缺性限制了該市場的成長。

此外，對遠端監控和遠距醫療的需求不斷增長、智慧胰島素筆製造商之間的聯盟與合作、經濟成長和個人化糖尿病管理預計將為市場成長創造機會。然而，新興國家對智慧胰島素筆的使用缺乏瞭解以及對傳統胰島素輸送技術的偏好是智慧胰島素筆市場的主要課題。

目錄

第1章簡介

第2章 研究方法

第3章 執行摘要

第4章 市場洞察

  • 概述
  • 促進因素
    • 糖尿病患者數量增加
    • 人們越來越偏愛數位健康解決方案
    • 智慧胰島素筆的技術進步
    • 自我用藥需求增加
    • 增加糖尿病意識計劃
  • 抑制因素
    • 智慧胰島素筆成本高
    • 智慧胰島素筆替代品的可用性
  • 機會
    • 遠端監控和遠距醫療的需求不斷增長
    • 與智慧胰島素筆公司的合作關係
    • 新興經濟體
    • 個人化糖尿病管理方案
  • 任務
    • 新興國家對智慧胰島素筆的使用缺乏認識
    • 偏好傳統胰島素給藥方法
  • 趨勢
    • 與連續血糖監測 (CGM) 系統集成
  • 因子分析
  • 監管分析
  • 價格分析
  • 母公司/鄰近市場分析
  • 波特五力分析

第5章智慧型胰島素筆市場評估：依產品

  • 概述
  • 可重複使用的胰島素筆
  • 一次性預充式胰島素筆
  • 胰島素筒
  • 配件

第6章 智慧胰島素筆市場評估：依連結性

  • 概述
  • 藍牙連接
  • 近場通訊 (NFC) 連接

第6章 智慧型胰島素筆市場評估：血糖儀相容性

  • 概述
  • 血糖監測儀 (BGM) 相容筆
  • 連續血糖監測儀 (CGM) 相容筆

第8章智慧型胰島素筆市場評估：按購買管道

  • 概述
  • 醫院藥房
  • 零售藥店
  • 線上/電子商務平台

第9章智慧型胰島素筆市場評估：按地區

  • 概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 奧地利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 拉丁美洲
  • 中東/非洲

第10章 競爭分析

  • 概述
  • 主要成長策略
  • 競爭標桿
  • 比賽儀表板
    • 產業領導者
    • 市場差異化因素
    • 龍頭企業
    • 啟動
  • 主要企業市佔率分析/市場排名（2023年）

第11章公司簡介（業務概況、財務概況、產品組合、策略發展、SWOT 分析*）

  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi S.A.
  • Medtronic plc
  • Emperra GmbH E-Health Technologies
  • pendiq GmbH
  • Jiangsu Delfu medical device Co., Ltd
  • Tandem Diabetes Care, Inc.
  • Ypsomed AG
  • Bigfoot Biomedical, Inc.

（註：提供前5名公司的SWOT分析）

第12章附錄

Product Code: MRHC - 1041300

Smart Insulin Pens Market Size, Share, Forecast, & Trends Analysis by Product (Reusable, Disposable Prefilled, Cartridge) Connectivity (Bluetooth, NFC) Compatibility (Blood Glucose Monitor, CGM) Channel (Hospital, Retail, Online)-Global Forecast to 2031

The smart insulin pens market is projected to reach $776.5 million by 2031 at a CAGR of 11.2% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the smart insulin pens market is driven by the rising incidence of diabetes, growing preference for digital health solutions, technological advancements in smart insulin pens, an increase in demand for drug self-administration, and initiatives worldwide toward diabetes awareness. However, the high cost of smart insulin pens, along with the low availability of alternatives, are restraining the growth of this market.

Furthermore, the rising demand for remote monitoring and telemedicine, partnerships and collaborations among smart insulin pen manufacturers, expanding economies, and personalized diabetes management are expected to generate market growth opportunities. However, a lack of understanding about the use of smart insulin pens in developing nations and a preference for traditional insulin delivery techniques are major challenges in the smart insulin pens market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years. The key players operating in the smart insulin pens market are Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Sanofi S.A. (France), Medtronic plc (Ireland), Emperra GmbH E-Health Technologies (Germany), pendiq GmbH (Germany), Jiangsu Delfu medical device Co., Ltd (China), Tandem Diabetes Care, Inc. (U.S.), Ypsomed AG (Switzerland), and Bigfoot Biomedical, Inc. (U.S.).

Among all products covered in this report, in 2024, the insulin cartridges segment is expected to account for the largest share of 63.3% of the smart insulin pen market. High diabetes incidence worldwide and technological advancements in insulin delivery systems are supporting the segment's largest share. Insulin cartridges offer ease of use and comfort to the patients. These also help in reducing drug wastage and providing accurate insulin dosing.

Among all connectivity covered in this report, in 2024, the Bluetooth connectivity segment is expected to account for the major share of the smart insulin pens market. The largest share is attributed to ease of data sharing, high range of connectivity, its integration with CGM systems, and access to real-time data. These factors offer convenience and flexibility to the user, which results in consumer preference for Bluetooth-connected smart insulin devices over insulin pens.

Among all glucose monitor compatibilities covered in this report, in 2024, the blood glucose monitor (BGM)-compatible pens segment to dominate the smart insulin pens market. The low cost of blood glucose monitors, high accuracy in results, and point-in-time ability to monitor blood glucose levels are the factors attributed to the largest share of the segment. Moreover, technological advancements in the monitors and compatibility with different smart insulin pens also support the segment's large market share.

Among all purchase channels covered in this report, in 2024, the retail pharmacies segment is expected to account for the largest share of 49.2% of the smart insulin pens market. The availability of retail pharmacies in the vicinities, the availability of a diverse range of products, and the chance to inspect the product before making a purchase attract consumers towards retail pharmacies. Moreover, the trustworthiness of pharmacists helps consumers make confident purchase decisions.

An in-depth analysis of the geographical scenario of the smart insulin pens market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Among all the geographies studied in this report, in 2024, North America is expected to account for the largest share of 35% of the smart insulin pens market. The presence of key market players, high healthcare spending, high patient population, and ease of accessibility to technologically advanced devices support the large share of this regional market.

Scope of the Report:

Smart Insulin Pens Market Assessment-By Product

  • Reusable Insulin Pens
  • Disposable Prefilled Insulin Pens
  • Insulin Cartridges
  • Accessories

Note: Accessories include data transmitters & injector ports.

Smart Insulin Pens Market Assessment-By Connectivity

  • Bluetooth Connectivity
  • Near Field Communication (NFC) Connectivity

Smart Insulin Pens Market Assessment-By Glucose Monitor Compatibility

  • Blood Glucose Monitor (BGM) Compatible Pens
  • Continuous Glucose Monitor (CGM) Compatible Pens

Smart Insulin Pens Market Assessment-By Purchase Channel

  • Purchase Channel
  • Retail Pharmacies
  • Online/E-commerce Platforms

Smart Insulin Pens Market Assessment-By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • Austria
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
  • 2.3. Market Sizing and Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. Increasing Number of Diabetes Cases
    • 4.2.2. Increasing Preference for Digital Health Solutions
    • 4.2.3. Technological Advancements in Smart Insulin Pens
    • 4.2.4. Increasing Demand for Self-Administration of Drugs
    • 4.2.5. Increasing Diabetes Awareness Programs
  • 4.3. Restraints
    • 4.3.1. High Cost of Smart Insulin Pens
    • 4.3.2. Availability of Alternatives to Smart Insulin Pens
  • 4.4. Opportunities
    • 4.4.1. Growing Demand for Remote Monitoring and Telemedicine
    • 4.4.2. Partnerships and Collaborations by the Smart Insulin Pens Companies
    • 4.4.3. Emerging Economies
    • 4.4.4. Personalized Diabetes Management Program
  • 4.5. Challenges
    • 4.5.1. Lack of Awareness Regarding the Use of Smart Insulin Pens in Developing Countries
    • 4.5.2. Preference for Traditional Insulin Delivery Methods
  • 4.6. Trends
    • 4.6.1. Integration with Continuous Glucose Monitoring (CGM) Systems
  • 4.7. Factor Analysis
  • 4.8. Regulatory Analysis
  • 4.9. Pricing Analysis
  • 4.10. Parent/Adjacent Market Analysis
  • 4.11. Porter's Five Forces Analysis

5. Smart Insulin Pens Market Assessment-by Product

  • 5.1. Overview
  • 5.2. Reusable Insulin Pens
  • 5.3. Disposable Prefilled Insulin Pens
  • 5.4. Insulin Cartridges
  • 5.5. Accessories

6. Smart Insulin Pens Market Assessment-by Connectivity

  • 6.1. Overview
  • 6.2. Bluetooth Connectivity
  • 6.3. Near Field Communication (NFC) Connectivity

7. Smart Insulin Pens Market Assessment-by Glucose Monitor Compatibility

  • 7.1. Overview
  • 7.2. Blood Glucose Monitors (BGMs) Compatible Pens
  • 7.3. Continuous Glucose Monitors (CGMs) Compatible Pens

8. Smart Insulin Pens Market Assessment-by Purchase Channel

  • 8.1. Overview
  • 8.2. Hospital Pharmacies
  • 8.3. Retail Pharmacies
  • 8.4. Online/E-commerce Platforms

9. Smart Insulin Pens Market Assessment-by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Austria
    • 9.3.7. Netherlands
    • 9.3.8. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Australia
    • 9.4.5. South Korea
    • 9.4.6. Australia
    • 9.4.7. Rest of Asia-Pacific
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competition Analysis

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies
  • 10.5. Market Share Analysis/Market Rankings of Key Players (2023)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

  • 11.1. Novo Nordisk A/S
  • 11.2. Eli Lilly and Company
  • 11.3. Sanofi S.A.
  • 11.4. Medtronic plc
  • 11.5. Emperra GmbH E-Health Technologies
  • 11.6. pendiq GmbH
  • 11.7. Jiangsu Delfu medical device Co., Ltd
  • 11.8. Tandem Diabetes Care, Inc.
  • 11.9. Ypsomed AG
  • 11.10. Bigfoot Biomedical, Inc.

(Note: SWOT analysis of the top 5 companies will be provided.)

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports

LIST OF TABLES

  • Table 1 Global Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 2 Global Reusable Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
  • Table 3 Global Disposable Prefilled Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
  • Table 4 Global Smart Insulin Pens Cartridges Market, by Country/Region, 2022-2031 (USD Million)
  • Table 5 Global Smart Insulin Pens Accessories, by Country/Region, 2022-2031 (USD Million)
  • Table 6 Global Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 7 Global Bluetooth Connected Smart Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
  • Table 8 Global Near Field Communication (NFC) Smart Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
  • Table 9 Global Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 10 Global Blood Glucose Monitors (BGMs) Compatible Smart Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
  • Table 11 Global Continuous Glucose Monitors (CGMs) Compatible Smart Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
  • Table 12 Global Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 13 Global Smart Insulin Pens Market for Hospital Pharmacies, by Country/Region, 2022-2031 (USD Million)
  • Table 14 Global Smart Insulin Pens Market for Retail Pharmacies, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global Smart Insulin Pens Market for Online/E-commerce Platforms, by Country/Region, 2022-2031 (USD Million)
  • Table 16 Global Smart Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
  • Table 17 North America: Smart Insulin Pens Market, by Country, 2022-2031 (USD Million)
  • Table 18 North America: Smart Insulin Pens Market, by product, 2022-2031 (USD Million)
  • Table 19 North America: Smart Insulin Pens Market, by connectivity, 2022-2031 (USD Million)
  • Table 20 North America: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 21 North America: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 22 U.S.: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 23 U.S.: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 24 U.S.: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 25 U.S.: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 26 Canada: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 27 Canada: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 28 Canada: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 29 Canada: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 30 Europe: Smart Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
  • Table 31 Europe: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 32 Europe: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 33 Europe: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 34 Europe: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 35 Germany: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 36 Germany: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 37 Germany: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 38 Germany: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 39 France: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 40 France: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 41 France: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 42 France: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 43 U.K.: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 44 U.K.: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 45 U.K.: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 46 U.K.: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 47 Italy: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 48 Italy: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 49 Italy: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 50 Italy: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 51 Spain: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 52 Spain: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 53 Spain: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 54 Spain: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 55 Austria: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 56 Austria: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 57 Austria: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 58 Austria: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 59 Netherlands: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 60 Netherlands: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 61 Netherlands: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 62 Netherlands: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 63 Rest of Europe: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 64 Rest of Europe: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 65 Rest of Europe: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 66 Rest of Europe: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 67 Asia-Pacific: Smart Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
  • Table 68 Asia-Pacific: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 69 Asia-Pacific: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 70 Asia-Pacific: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 71 Asia-Pacific: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 72 Japan: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 73 Japan: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 74 Japan: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 75 Japan: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 76 China: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 77 China: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 78 China: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 79 China: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 80 India: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 81 India: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 82 India: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 83 India: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 84 South Korea: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 85 South Korea: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 86 South Korea: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 87 South Korea: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 88 Australia: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 89 Australia: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 90 Australia: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 91 Australia: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 92 Rest of Asia-Pacific: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 93 Rest of Asia-Pacific: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 94 Rest of Asia-Pacific: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 95 Rest of Asia-Pacific: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 96 Latin America: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 97 Latin America: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 98 Latin America: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 99 Latin America: Smart Insulin Pens Market, by Purchase Channel, 2022-2031 (USD Million)
  • Table 100 Middle East & Africa: Smart Insulin Pens Market, by Product, 2022-2031 (USD Million)
  • Table 101 Middle East & Africa: Smart Insulin Pens Market, by Connectivity, 2022-2031 (USD Million)
  • Table 102 Middle East & Africa: Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2022-2031 (USD Million)
  • Table 103 Middle East & Africa: Smart Insulin Pens Market, by purchase Channel, 2022-2031 (USD Million)
  • Table 104 Recent Developments, by Company, 2021-2024

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Smart Insulin Pens Market, by Product, 2024 VS. 2031 (USD Million)
  • Figure 8 Global Smart Insulin Pens Market, by Connectivity, 2024 VS. 2031 (USD Million)
  • Figure 9 Global Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2024 VS. 2031 (USD Million)
  • Figure 10 Global Smart Insulin Pens Market, by Purchase Channel, 2024 VS. 2031 (USD Million)
  • Figure 11 Global Smart Insulin Pens Market, by Geography
  • Figure 12 Impact Analysis: Smart Insulin Pens Market
  • Figure 13 Global Smart Insulin Pens Market, by Product, 2024 VS. 2031 (USD Million)
  • Figure 14 Global Smart Insulin Pens Market, by Connectivity, 2024 VS. 2031 (USD Million)
  • Figure 15 Global Smart Insulin Pens Market, by Glucose Monitor Compatibility, 2024 VS. 2031 (USD Million)
  • Figure 16 Global Smart Insulin Pens Market, by Purchase Channel, 2024 VS. 2031 (USD Million)
  • Figure 17 Global Smart Insulin Pens Market, by Geography, 2024 VS. 2031 (USD Million)
  • Figure 18 North America: Smart Insulin Pens Market Snapshot
  • Figure 19 Europe: Smart Insulin Pens Market Snapshot
  • Figure 20 Asia-Pacific: Smart Insulin Pens Market Snapshot
  • Figure 21 Key Growth Strategies Adopted by Leading Players, 2022-2024
  • Figure 22 Global Smart Insulin Pens Market: Competitive Benchmarking, by Product
  • Figure 23 Global Smart Insulin Pens Market: Competitive Benchmarking, by Geography
  • Figure 24 Global Smart Insulin Pens Market: Competitive Dashboard
  • Figure 25 Global Smart Insulin Pens Market: Market Share Analysis/Market Ranking, By Key Players, 2024
  • Figure 26 Novo Nordisk A/S: Financial Overview (2024)
  • Figure 27 Eli Lilly and Company: Financial Overview (2024)
  • Figure 28 Sanofi S.A.: Financial Overview (2024)
  • Figure 29 Medtronic plc: Financial Overview (2024)
  • Figure 30 Emperra GmbH E-Health Technologies: Financial Overview (2024)
  • Figure 31 Tandem Diabetes Care, Inc.: Financial Overview (2024)
  • Figure 32 Ypsomed AG (Switzerland): Financial Overview (2024)